Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Artivion, Inc. stock logo
AORT
Artivion
$22.93
-0.7%
$25.19
$19.36
$32.33
$978.65M1.65294,415 shs249,116 shs
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
$21.91
-1.6%
$24.71
$14.84
$29.55
$1.04B1.93376,628 shs529,574 shs
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
$17.74
+5.0%
$17.39
$6.60
$25.00
$1.19B1.87197,103 shs132,204 shs
ZimVie Inc. stock logo
ZIMV
ZimVie
$9.39
+1.5%
$11.62
$8.56
$22.40
$261.48M2.14223,837 shs103,687 shs
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Artivion, Inc. stock logo
AORT
Artivion
-0.46%-2.57%-5.12%-25.47%+14.68%
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
-1.57%+4.38%-13.50%-16.18%+44.72%
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
+5.03%+14.01%+10.94%+0.74%+137.48%
ZimVie Inc. stock logo
ZIMV
ZimVie
+1.51%+3.53%-21.88%-34.29%-38.75%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Artivion, Inc. stock logo
AORT
Artivion
2.947 of 5 stars
3.51.00.00.02.82.51.9
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
2.2539 of 5 stars
3.51.00.00.02.72.50.6
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
1.0631 of 5 stars
0.00.00.04.22.83.30.0
ZimVie Inc. stock logo
ZIMV
ZimVie
2.5902 of 5 stars
3.53.00.00.02.81.70.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Artivion, Inc. stock logo
AORT
Artivion
3.00
Buy$31.4036.97% Upside
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
3.00
Buy$31.1742.25% Upside
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
0.00
N/AN/AN/A
ZimVie Inc. stock logo
ZIMV
ZimVie
3.00
Buy$19.50107.67% Upside

Current Analyst Ratings Breakdown

Latest ZIMV, BLFS, PLSE, and AORT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/10/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$16.00
4/9/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
4/9/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
3/13/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Hold
3/6/2025
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$27.00 ➝ $30.00
2/27/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$23.00 ➝ $23.00
2/25/2025
Artivion, Inc. stock logo
AORT
Artivion
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$33.00 ➝ $30.00
2/25/2025
Artivion, Inc. stock logo
AORT
Artivion
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$34.00 ➝ $32.00
1/28/2025
Artivion, Inc. stock logo
AORT
Artivion
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$34.00 ➝ $34.00
(Data available from 4/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Artivion, Inc. stock logo
AORT
Artivion
$388.54M2.52$0.62 per share36.78$6.87 per share3.34
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
$82.25M12.65N/AN/A$7.67 per share2.86
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
$700K1,704.92N/AN/A$0.81 per share21.90
ZimVie Inc. stock logo
ZIMV
ZimVie
$449.75M0.58$3.39 per share2.77$15.43 per share0.61
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Artivion, Inc. stock logo
AORT
Artivion
-$30.69M-$0.31N/A45.85N/A-0.22%5.15%1.91%5/5/2025 (Estimated)
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
-$66.43M-$0.50N/AN/AN/A-38.98%-6.61%-5.54%5/8/2025 (Estimated)
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
-$42.21MN/A0.00N/AN/A-96.89%-74.83%5/5/2025 (Estimated)
ZimVie Inc. stock logo
ZIMV
ZimVie
-$393.28M-$0.95N/AN/A-77.31%2.90%1.17%5/14/2025 (Estimated)

Latest ZIMV, BLFS, PLSE, and AORT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2025Q1 2025
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
-$0.03N/AN/AN/A$22.22 millionN/A
5/5/2025Q1 2025
Artivion, Inc. stock logo
AORT
Artivion
$0.12N/AN/AN/A$94.81 millionN/A
3/3/2025Q4 2024
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
-$0.06$0.26+$0.32$0.26$21.73 million$22.71 million
2/26/2025Q4 2024
ZimVie Inc. stock logo
ZIMV
ZimVie
$0.25$0.27+$0.02-$0.43$113.67 million$111.52 million
2/24/2025Q4 2024
Artivion, Inc. stock logo
AORT
Artivion
$0.12-$0.39-$0.51-$0.39$100.82 million$97.31 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Artivion, Inc. stock logo
AORT
Artivion
N/AN/AN/AN/AN/A
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
N/AN/AN/AN/AN/A
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
N/AN/AN/AN/AN/A
ZimVie Inc. stock logo
ZIMV
ZimVie
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Artivion, Inc. stock logo
AORT
Artivion
0.71
1.88
1.33
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
0.03
2.78
1.78
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
N/A
11.93
11.93
ZimVie Inc. stock logo
ZIMV
ZimVie
0.57
1.94
1.38

Institutional Ownership

CompanyInstitutional Ownership
Artivion, Inc. stock logo
AORT
Artivion
86.37%
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
93.24%
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
76.95%
ZimVie Inc. stock logo
ZIMV
ZimVie
95.63%

Insider Ownership

CompanyInsider Ownership
Artivion, Inc. stock logo
AORT
Artivion
8.10%
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
2.20%
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
71.50%
ZimVie Inc. stock logo
ZIMV
ZimVie
3.01%
CompanyEmployeesShares OutstandingFree FloatOptionable
Artivion, Inc. stock logo
AORT
Artivion
1,30042.69 million38.52 millionOptionable
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
44047.50 million45.37 millionOptionable
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
14067.27 million17.53 millionOptionable
ZimVie Inc. stock logo
ZIMV
ZimVie
2,70027.85 million26.77 millionOptionable

Recent News About These Companies

Zimmer Biomet Hits 34th 52-Week Low: Value Play or Value Trap?
What is B. Riley's Forecast for ZimVie Q1 Earnings?
ZimVie Inc. stock logo
B. Riley Weighs in on ZimVie's Q1 Earnings (NASDAQ:ZIMV)
ZimVie (NASDAQ:ZIMV) Coverage Initiated at B. Riley
Needham Remains a Hold on ZimVie Inc (ZIMV)
ZimVie initiated with a Buy at B. Riley
ZimVie shuffles board of directors
Needham Downgrades ZimVie (ZIMV)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Artivion stock logo

Artivion NYSE:AORT

$22.92 -0.16 (-0.67%)
Closing price 04/17/2025 03:59 PM Eastern
Extended Trading
$22.94 +0.01 (+0.04%)
As of 04/17/2025 04:07 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company provides BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and aortic arch stent grafts including E-vita Open Plus and E-vita Open Neo. It offers E-xtra design engineering systems for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, a stent graft system for the treatment of infrarenal abdominal aortic aneurysms. In addition, the company offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; cardiac laser therapy products for angina treatment; CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; On-X prosthetic aortic and mitral heart valves and the On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as pyrolytic carbon coating services to medical device manufacturers. It serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion, Inc. in January 2022. Artivion, Inc. was incorporated in 1984 and is headquartered in Kennesaw, Georgia.

BioLife Solutions stock logo

BioLife Solutions NASDAQ:BLFS

$21.91 -0.35 (-1.57%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$21.89 -0.02 (-0.09%)
As of 04/17/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line that comprises of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides cryogenic freezer technology for controlled rate freezing and cryogenic storage of biologic materials; ultra-low temperature mechanical freezers; evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage and transport services. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.

Pulse Biosciences stock logo

Pulse Biosciences NASDAQ:PLSE

$17.74 +0.85 (+5.03%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$17.70 -0.04 (-0.23%)
As of 04/17/2025 04:07 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.

ZimVie stock logo

ZimVie NASDAQ:ZIMV

$9.39 +0.14 (+1.51%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$9.39 0.00 (0.00%)
As of 04/17/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment. The company offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name. It provides bone grafts, barrier membranes, and collagen wound care products; virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and intra-oral scanners; and Implant Concierge, a web-based treatment planning and surgery guide service. In addition, the company designs, manufactures, and distributes spinal fusion implants, instrumentation for various spinal procedures, biologics, and bone healing technologies. Further, it provides MIS solutions that deliver implant and instrumentation systems; and motion preservation solutions that offer non-fusion alternatives for cervical disc implant or growth modulation for anterior vertebral body tethering. The company sells its products to oral surgeons, dental specialists, general dentists, dental laboratories, and other dental organizations, including DSOs, as well as educational, medical, and governmental entities, hospitals, and surgery centers through direct sales representatives, agents, and distributors. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.